Internal Medicine, Gastroenterology · Nashville, TN
NPI
1760478192
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2400 Patterson St, Suite 400
Nashville, TN, 37203
Phone (615) 342-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$89K
925 services
Medicare patients, 2024
504
Average age 74
Drug cost, 2024
$467K
1,606 prescriptions
Company payments, 2025
$1,854
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas J Lewis was code 99213 (office e&m - established), 157 times for 107 patients. In total Thomas J Lewis billed 925 services in 45 codes, and Medicare paid $89K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 157 | 107 | $60.05 | $9,429 |
| 45380 Lower GI Endoscopy - Other | Facility | 135 | 135 | $122.94 | $17K |
| 99214 Office E&M - Established | Office | 95 | 65 | $87.78 | $8,339 |
| 43239 Upper GI Endoscopy | Facility | 94 | 92 | $68.66 | $6,454 |
| 99232 Hospital E&M - Subsequent | Facility | 55 | 32 | $57.62 | $3,169 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 55 | 55 | $166.36 | $9,150 |
| 45385 Colonoscopy - Lesion Removal | Facility | 50 | 50 | $190.30 | $9,515 |
| 43235 Upper GI Endoscopy | Facility | 40 | 40 | $66.53 | $2,661 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 30 | 30 | $166.48 | $4,994 |
| 99222 Hospital E&M - Initial | Facility | 24 | 24 | $86.64 | $2,079 |
| 43249 Upper GI Endoscopy | Facility | 23 | 22 | $98.29 | $2,261 |
| 45378 Lower GI Endoscopy - Other | Facility | 23 | 23 | $120.08 | $2,762 |
| 99231 Hospital E&M - Subsequent | Facility | 21 | 17 | $34.72 | $729 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $127.98 | $2,304 |
| 43248 Upper GI Endoscopy | Facility | 14 | 14 | $111.55 | $1,562 |
By year: 2022 $119K for 1,218 services; 2023 $79K for 793 services; 2024 $89K for 925 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas J Lewis prescribed most often to Medicare patients was Pantoprazole Sodium, with 343 prescriptions and refills. In total Thomas J Lewis wrote 1,606 Medicare prescriptions that cost $467K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 343 | 914 | 121 | $5,339 |
| Famotidine Generic | 190 | 563 | 75 | $3,429 |
| Omeprazole Generic | 108 | 262 | 26 | $1,772 |
| Sucralfate Generic | 92 | 172 | 39 | $4,543 |
| Metoclopramide Hcl Generic | 82 | 112 | 30 | $472 |
| Dicyclomine Hcl Generic | 75 | 128 | 26 | $1,977 |
| Linzess Linaclotide | 70 | 91 | 14 | $48K |
| Budesonide Dr Budesonide | 61 | 108 | 17 | $19K |
| Esomeprazole Magnesium Generic | 58 | 131 | 15 | $2,254 |
| Creon Lipase/Protease/Amylase | 31 | 42 | Under 11 | $98K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 29 | 35 | Under 11 | $821 |
| Ursodiol Generic | 25 | 46 | Under 11 | $3,126 |
| Meloxicam Generic | 24 | 36 | Under 11 | $121 |
| Dexlansoprazole Dr Dexlansoprazole | 24 | 36 | Under 11 | $5,247 |
| Promethazine Hcl Generic | 22 | 23 | Under 11 | $204 |
Brand drugs: - claims; generic drugs: 1,373 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas J Lewis $1,854 ($1,854 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $993.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 83 | $993 |
| Genzyme Corporation SNY | 13 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $145 |
| Phathom Pharmaceuticals, Inc. PHAT | 10 | $86.4 |
| Lilly USA, LLC LLY | 4 | $80.34 |
| Celltrion USA Inc. 068270.KS | 3 | $61.25 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $55.65 |
| Aimmune Therapeutics, Inc. | 2 | $40.41 |
| Madrigal Pharmaceuticals MDGL | 2 | $36.24 |
| Janssen Biotech, Inc. JNJ | 1 | $25.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.